drugset / Trial / NCT01799863

Artificial Tears Versus Preservative Free Ketorolac Trometamol 0.45% for Acute Viral Conjunctivitis

NCT01799863

Phase 2/3 Completed 50 enrolled Fundação Altino Ventura
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the evolution of the symptoms of acute viral conjunctivitis using preservative free ketorolac trometamol 0.45% associated with carboxymethylcellulose compared with isolated use of preservative-free artificial tears.

Timeline

Start
2012-06
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified 0.45 % Topical

Indications